Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Ex is doing his job.
Got you to sell, and sell early.
The posters are made available on Monday morning.
The first oral presentations of the posters are on Wednesday and Friday.
Maybe a PR about SITC on Tuesday and a PR about TLD on Monday morning.
Maybe, because their abstract data will be presented at SITC?
I guess my question to you is, if they are waiting, why did they not withdraw from SITC first?
He is a trader.
Plays both sides of the fence.
That would be from the price explosion to the upside.
Bravo, Flip.
Great rebuttal, and so true.
If you read the previous posts from the ones i highlighted, it is like reading the NWBO board today. Good Luck to you and all longs.
Don't give up your shares to the manipulators!
Nice work, Kam.
I remember reading the all the posts after that happened, and saw the same type posts I see here. Just an example, right before the explosion.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=119931999
Seems that nothing can move this today...
What are the latest trial completion date estimates around here, if I may be so bold as to ask? I know, "news any day now," but that's a phrase I've often found myself repeating for months in a row...
Or this...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=119878910
Well I bought some 128's on the 2nd trip down today; don't see any reason not to take advantage of the price. WRT current price, the daily tape decline and all time low price going into results do not make allot of sense to me. There is certainly a group (or two) behind the scenes setting the price they think they need; very easy to do on a low floater in a sector washout. Believe we will be just fine, beleive that group behind the scenes is just buying up all they can in the sell off... we shall see.
Bye-Bye.
50 bucks the Smails kid picks his nose...
Well, we're waiting....
By Height
Oh, so you're the wife?
Bet you were somethin' before electricity!
Damn!
You can owe me!
I owe you nothing!
Hundred bucks you slice into the woods!
I never said LP was stupid, quite the opposite.
Is there a minimum of days trading above 3 dollars to gain approval for listing?
Basin,
FWIW, I am in your camp of a hedge fund accumulating.
The trading on this run has been way to orderly for a leak.
Hmmmm, a new platform?
Where have I heard that?
The results boost Gilead’s hopes of finding a “platform in a product.” While some analysts questioned whether the deal was worth the cost, SVB Leerink’s Geoffrey Porges said Gilead anticipated the ESMO data would “alter (positively) investor’s perceptions of the drug and would have created significant upwards pressure on the company’s value (thus justifying their lofty premium).”
https://endpts.com/esmo20-trodelvy-data-shows-big-gilead-buyout-may-have-been-worth-the-premium/
I used to really like your observations back in the day.
However, what you write now appears to be sour grapes.
You seem perturbed that you may miss out on a truly amazing story.
Bury the anger, and either get back in, or just let it go.
Nothing, really, except she's lying, Again.
Not me, it's Lincoln Park Capital, the Vulture Fund, shorting this as usual. If they didn't have a line of credit with that POS, the stock would be over 10 bucks. I can't believe they still work with these losers.
Well maybe one more....
My son goes to the toughest school in the state.
His English teacher asked the class...
What comes after a sentence?
A kid jumps up and says...
You make an appeal!
CYRX was very good to me, but I held it for a long, long time.
I bought it when that idiot Stambaugh was the CEO. He was an idiot. Couple reverse splits, but held on and bought into the offering, which turned out to be a good deal. They adjusted you for the reverse split.
I am now, as you are, waiting on NWBO, one of their customers.
Hope I have the same luck there.
I had some non trade able warrants, and the exercise price was $3.57.
They also had to be held at for 6 months after exercise.
Here is the link to the Henry Ford study...
https://www.henryford.com/news/2020/07/hydro-treatment-study
They were not in compliance as the price was under a dollar for over 30 days. It is not that big a deal, as they would have to the end of December to be above a dollar for 10 days to get back in compliance.
They achieved this today, as this was the 10th day of the closing price being above $1.
Nice work, Longfellow.
I do not understand why all the fake news to try and disparage a treatment that has been around for 60 years. Maybe it is too cheap, and big pharma needs to make billions. Funny how Fauci gets behind all these experimental drugs that fail. I know from personal friends that this drug works for the Wuhan Flu, sometimes within hours.
This is quite a stretch, isn't it?
I'll stretch you one further.
She was a CPA. I know a few CPA's.
Being a CPA and a CFO are 2 different things.
Maybe she couldn't handle it, let alone 3 titles.
Just kidding Longfellow.
Appreciate all your work.
Well, if he doesn't, and you have some spare time, I have a few things you could look into, if you don't mind. Asking for a friend.
More like Christopher Steele!
Its ridiculous.
They would rather have you die, then say anything he does is correct.
That should tell everyone how they feel about you, and only being in power matters to them. Same for the media. As Americans, we should not tolerate this. Everyone should be incensed. They would rather you stay locked down, without a job, than give you a drug that has been safe for 60 years. Side effects, every drug has side effects for some. Tylenol will rot your liver, but is sold in every store in the world. Just ponder that for a moment.
Maybe Christopher Steele wrote the data.
Seems like news has leaked.
Too much volume with nice price spike
The short position in CYRX is 22.5%.
Pretty big position.
For the quarter, it seems bullish that they met revenue expectations, as a lot of firms are struggling to do so.
"In April, Gilead's Kite Pharma renewed its agreement with Cryoport, which cover its entire portfolio of therapies in development as well as YESCARTA®. The ongoing rollouts of both YESCARTA® and KYMRIAH® to patients in the Americas, EMEA and APAC are expected to drive a continued ramp in activity related to our agreements supporting these commercial products. Revenue from our agreement with bluebird bio to support its commercial launch of ZYNTEGLO™ is expected to commence in the second half of 2020."
May see a short attack in the morning, but don't think it will last